Key Takeaways
- The US Court of Appeals has banned Apple from selling watches with blood oxygen sensors in the US due to an intellectual property dispute with Masimo.
- The affected Apple Watch models are the Series 9 and Ultra 2, which will no longer be imported into the US.
- Retailers with the affected devices in stock may still sell them, but Apple will no longer import or sell new devices with blood oxygen sensors.
San Francisco: Apple will be banned from selling watches with blood oxygen sensors beginning Thursday in the United States, the U.S. Court of Appeals for the Federal Circuit said.
The ban stems from an intellectual property dispute with Masimo, a medical device company. In October, the International Trade Commission found that Apple’s blood oxygen sensors had infringed on Masimo’s intellectual property.
The ban prevents Apple from importing the devices in question, which involve Apple Watch Series 9 and Ultra 2.
In December, Apple briefly removed the affected watches from its online and retail stores, while retailers with those devices in stock may still sell them.
Earlier this week, court filings suggested that Apple had received approval from the U.S. Customs for a modified version of its Apple watches that lack the blood oxygen feature.
